Back to search
FDAFDA · Food and drugs·Recall number D-1081-2015

Olanzapine, Orally Disintegrating Tablets, 20 mg, 30-count bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9

Published May 20, 2015 · Recall initiated: April 7, 2015

Summary

FDA records drug Class III recall D-1081-2015, published May 20, 2015 and initiated April 7, 2015. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 5,352 bottles; Lot: Lot # KL0664, Exp 04/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide
Lot
Lot # KL0664, Exp 04/15
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Olanzapine, Orally Disintegrating Tablets, 20 mg, 30-count bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9 recalled?

Yes. FDA published recall D-1081-2015 on May 20, 2015. Reported hazard: Subpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter